Usana Health Sciences Inc
USNA
Get informed when a big investor buys or sells
+ FollowMarket Cap$382.18M
Close$
$61.41
185.5% upside
Current Fair Value
185.5% upsideUndervalued by 185.5% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $382.18 Million |
|---|---|
| Enterprise Value | $233.43 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $0.58 |
| Beta | 0.77 |
| Outstanding Shares | 18,398,000 |
Return
| Return on Equity | 1.63% |
|---|---|
| Return on Assets | 1.20% |
| Return on Invested Capital | 8.37% |
Valuation & Multiples
| P/E Ratio | 43.76 |
|---|---|
| PEG | -218.05 |
| Price to Sales | 0.43 |
| Price to Book Ratio | 0.67 |
| Enterprise Value to Revenue | 0.25 |
| Enterprise Value to EBIT | 4.49 |
| Enterprise Value to Net Income | 26 |
| Total Debt to Enterprise | 0.06 |
| Debt to Equity | 0.03 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
May 5, 2026
EPS Estimate
$0.44
Average shareholder expectationRevenue Estimate
$240.99 M
Average shareholder expectationNext Earnings Call
Expected Date
July 28, 2026
EPS Estimate
$0.43
Average shareholder expectationRevenue Estimate
$235.00 M
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | 10,100▼ 21.09% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 56.15%▼ 0.29% |
|---|---|
| Total Invested | $179.59M▼ 12.76% |
| Investors Holding | 140▲ 20.00% |
ESG Score
No data
About Usana Health Sciences Inc
CEO: Kevin Guest